Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities

Background: In 2017, WHO recognized scabies as a neglected tropical disease. The optimal treatment is not well defined in some communities. Objective: This study aimed to compare ivermectin and benzyl benzoate in the treatment of scabies in Koranic schools (or "daara") in Dakar (region)....

Full description

Bibliographic Details
Main Authors: Ly Fatimata, Faye Adama, Wone Issa, Lelo Souleye, Diouf Astou, Koundio Abou, Ndiaye Diop Mame Tene, Gueye Diagne Fatou, Deh Aminata, Faye Babacar, Toure Fall Awa Oumar, Mahé Antoine, Tall Dia Anta
Format: Article
Language:English
Published: YCAB Publisher 2021-12-01
Series:Public Health of Indonesia
Subjects:
Online Access:https://stikbar.org/ycabpublisher/index.php/PHI/article/view/456
_version_ 1797988813236076544
author Ly Fatimata
Faye Adama
Wone Issa
Lelo Souleye
Diouf Astou
Koundio Abou
Ndiaye Diop Mame Tene
Gueye Diagne Fatou
Deh Aminata
Faye Babacar
Toure Fall Awa Oumar
Mahé Antoine
Tall Dia Anta
author_facet Ly Fatimata
Faye Adama
Wone Issa
Lelo Souleye
Diouf Astou
Koundio Abou
Ndiaye Diop Mame Tene
Gueye Diagne Fatou
Deh Aminata
Faye Babacar
Toure Fall Awa Oumar
Mahé Antoine
Tall Dia Anta
author_sort Ly Fatimata
collection DOAJ
description Background: In 2017, WHO recognized scabies as a neglected tropical disease. The optimal treatment is not well defined in some communities. Objective: This study aimed to compare ivermectin and benzyl benzoate in the treatment of scabies in Koranic schools (or "daara") in Dakar (region). Methods: This was a prospective randomized trial conducted from January to October 2018 in Senegal. Any resident living in the selected "daara" and diagnosed with scabies was included. The administered treatments were benzyl benzoate (BB) or ivermectin. At the outset, if one case of scabies was diagnosed, all residents received treatment. Ivermectin was given at the dose of 200 mg/kg. The same treatment was repeated on day 7 for each group, the endpoint was at D14, and the data were analyzed with STATA 14. Results: Fifteen "daara" were included. Of the 959 residents, 70 were diagnosed with scabies: prevalence of 7.29%. All patients except one were male; the mean age was 9.98 years (4-17). At D14, in the BB arm, cure rate was 42.85% (n = 15) while in the ivermectin arm, this rate was 5.71% (n = 2) with a significant difference (p = 0.01). On D28, the cure rate was still higher in the BB group 57.14 (n=20) versus ivermectin 21.42 (n = 6) with a significant difference (p = 0.004). On D42, all patients except eight were cured. At D14, we found a link between the cure rate, the number of people in the room (p = 0.01), and the number of showers per week (p = 0.01) but no link with the number of people per "daara" (p = 0.163). At D28, we found a link between the cure rate, the number of people sleeping in the room (p = 0.03), and the number of showers per week (p = 0.01) but not with the number of people per "daara" (p = 0.07). Conclusion: In Koranic schools, the cure rate is higher with benzyl benzoate compared to ivermectin.
first_indexed 2024-04-11T08:10:08Z
format Article
id doaj.art-307d8d3362974c349f4f3b41d7c9fc72
institution Directory Open Access Journal
issn 2528-1542
2477-1570
language English
last_indexed 2024-04-11T08:10:08Z
publishDate 2021-12-01
publisher YCAB Publisher
record_format Article
series Public Health of Indonesia
spelling doaj.art-307d8d3362974c349f4f3b41d7c9fc722022-12-22T04:35:23ZengYCAB PublisherPublic Health of Indonesia2528-15422477-15702021-12-017417218110.36685/phi.v7i4.456327Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalitiesLy Fatimata0Faye Adama1Wone Issa2Lelo Souleye3Diouf Astou4Koundio Abou5Ndiaye Diop Mame Tene6Gueye Diagne Fatou7Deh Aminata8Faye Babacar9Toure Fall Awa Oumar10Mahé Antoine11Tall Dia Anta12Dermatology/STI, EPS 1 Institut d'Hygiène Sociale de Dakar, Senegal | University Cheikh Anta Diop of Dakar, SenegalDepartment of Public Health, University Cheikh Anta Diop of Dakar, SenegalUniversity Assane Seck de Ziguinchor, SenegalDepartment of Parasitology-Mycology, University Cheikh Anta Diop, Dakar, SenegalDermatology/STI, EPS 1 Institut d'Hygiène Sociale de Dakar, SenegalLaboratory of Hematology, National Teaching Hospital Aristide Le Dantec, Dakar, SenegalDermatology/STI, EPS 1 Institut d'Hygiène Sociale de Dakar, SenegalDermatology/STI, EPS 1 Institut d'Hygiène Sociale de Dakar, SenegalDermatology/STI, EPS 1 Institut d'Hygiène Sociale de Dakar, SenegalDepartment of Parasitology-Mycology, University Cheikh Anta Diop, Dakar, SenegalLaboratory of Hematology, National Teaching Hospital Aristide Le Dantec, Dakar, SenegalHí´pital Louis Pasteur, Colmar, FranceISED Institut Sante et Développement, Mbour, SenegalBackground: In 2017, WHO recognized scabies as a neglected tropical disease. The optimal treatment is not well defined in some communities. Objective: This study aimed to compare ivermectin and benzyl benzoate in the treatment of scabies in Koranic schools (or "daara") in Dakar (region). Methods: This was a prospective randomized trial conducted from January to October 2018 in Senegal. Any resident living in the selected "daara" and diagnosed with scabies was included. The administered treatments were benzyl benzoate (BB) or ivermectin. At the outset, if one case of scabies was diagnosed, all residents received treatment. Ivermectin was given at the dose of 200 mg/kg. The same treatment was repeated on day 7 for each group, the endpoint was at D14, and the data were analyzed with STATA 14. Results: Fifteen "daara" were included. Of the 959 residents, 70 were diagnosed with scabies: prevalence of 7.29%. All patients except one were male; the mean age was 9.98 years (4-17). At D14, in the BB arm, cure rate was 42.85% (n = 15) while in the ivermectin arm, this rate was 5.71% (n = 2) with a significant difference (p = 0.01). On D28, the cure rate was still higher in the BB group 57.14 (n=20) versus ivermectin 21.42 (n = 6) with a significant difference (p = 0.004). On D42, all patients except eight were cured. At D14, we found a link between the cure rate, the number of people in the room (p = 0.01), and the number of showers per week (p = 0.01) but no link with the number of people per "daara" (p = 0.163). At D28, we found a link between the cure rate, the number of people sleeping in the room (p = 0.03), and the number of showers per week (p = 0.01) but not with the number of people per "daara" (p = 0.07). Conclusion: In Koranic schools, the cure rate is higher with benzyl benzoate compared to ivermectin.https://stikbar.org/ycabpublisher/index.php/PHI/article/view/456scabiesivermectinbenzyl benzoatekoranic schoolsenegalprospective studies
spellingShingle Ly Fatimata
Faye Adama
Wone Issa
Lelo Souleye
Diouf Astou
Koundio Abou
Ndiaye Diop Mame Tene
Gueye Diagne Fatou
Deh Aminata
Faye Babacar
Toure Fall Awa Oumar
Mahé Antoine
Tall Dia Anta
Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities
Public Health of Indonesia
scabies
ivermectin
benzyl benzoate
koranic school
senegal
prospective studies
title Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities
title_full Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities
title_fullStr Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities
title_full_unstemmed Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities
title_short Scabies in Koranic schools in Dakar, Senegal: Comparison of two therapeutic modalities
title_sort scabies in koranic schools in dakar senegal comparison of two therapeutic modalities
topic scabies
ivermectin
benzyl benzoate
koranic school
senegal
prospective studies
url https://stikbar.org/ycabpublisher/index.php/PHI/article/view/456
work_keys_str_mv AT lyfatimata scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT fayeadama scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT woneissa scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT lelosouleye scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT dioufastou scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT koundioabou scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT ndiayediopmametene scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT gueyediagnefatou scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT dehaminata scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT fayebabacar scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT tourefallawaoumar scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT maheantoine scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities
AT talldiaanta scabiesinkoranicschoolsindakarsenegalcomparisonoftwotherapeuticmodalities